Suppr超能文献

评价巴西亚马逊地区四个地区对间日疟原虫裂殖子表面蛋白-1的 Pv200L N 端片段的天然获得性抗体免疫应答。

Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.

机构信息

University of São Paulo State Júlio Mesquita Filho, São José do Rio Preto, São Paulo State, Brazil.

出版信息

Am J Trop Med Hyg. 2011 Feb;84(2 Suppl):58-63. doi: 10.4269/ajtmh.2011.10-0044.

Abstract

Frequency and levels of IgG antibodies to an N-terminal fragment of the Plasmodium vivax MSP-1 (Pv200L) protein, in individuals naturally exposed to malaria in four endemic areas of Brazil, were evaluated by enzyme-linked immunosorbent assay. Plasma samples of 261 P. vivax-infected individuals from communities of Macapá, Novo Repartimento, Porto Velho, and Plácido de Castro in the Amazonian region with different malaria transmission intensities. A high mean number of studied individuals (89.3%) presented with antibodies to the Pv200L that correlated with the number of previous malaria infections; there were significant differences in the frequency of the responders (71.9-98.7) and in the antibody levels (1:200-1:51,200) among the four study areas. Results of this study provide evidence that Pv200L is a naturally immunogenic fragment of the PvMSP-1 and is associated with the degree of exposure to parasites. The fine specificity of antibodies to Pv200L is currently being assessed.

摘要

采用酶联免疫吸附试验(ELISA),评估了自然感染疟原虫的个体中,针对恶性疟原虫 MSP-1(Pv200L)N 端片段的 IgG 抗体的频率和水平。对亚马孙地区的马卡帕、新雷波迪罗、波多韦柳和普拉西多·德卡斯特罗四个流行区社区中 261 名感染恶性疟原虫的个体的血浆样本进行了研究。结果显示,研究对象中约有 89.3%的人对 Pv200L 存在抗体,这与之前感染疟疾的次数有关;在四个研究区域中,应答者的频率(71.9-98.7)和抗体水平(1:200-1:51,200)存在显著差异。本研究结果表明,Pv200L 是恶性疟原虫 MSP-1 中一种天然免疫原性片段,与寄生虫暴露程度有关。目前正在评估针对 Pv200L 的抗体的精细特异性。

相似文献

引用本文的文献

1
Development and longevity of naturally acquired antibody and memory B cell responses against Plasmodium vivax infection.
PLoS Negl Trop Dis. 2024 Oct 24;18(10):e0012600. doi: 10.1371/journal.pntd.0012600. eCollection 2024 Oct.
2
vaccine: What is the best way to go?
Front Immunol. 2023 Jan 16;13:910236. doi: 10.3389/fimmu.2022.910236. eCollection 2022.
4
Progress towards the development of a vaccine.
Expert Rev Vaccines. 2021 Feb;20(2):97-112. doi: 10.1080/14760584.2021.1880898. Epub 2021 Mar 4.
8
Genetic diversity of MSP1 Block 2 of Plasmodium vivax isolates from Manaus (central Brazilian Amazon).
J Immunol Res. 2014;2014:671050. doi: 10.1155/2014/671050. Epub 2014 Feb 27.
9
N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine.
Clin Dev Immunol. 2013;2013:965841. doi: 10.1155/2013/965841. Epub 2013 Sep 28.

本文引用的文献

4
Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.
PLoS One. 2008;3(10):e3571. doi: 10.1371/journal.pone.0003571. Epub 2008 Oct 29.
7
Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians.
Clin Vaccine Immunol. 2007 Oct;14(10):1249-59. doi: 10.1128/CVI.00243-07. Epub 2007 Aug 15.
10
A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection--a review.
Mem Inst Oswaldo Cruz. 2006 May;101(3):229-37. doi: 10.1590/s0074-02762006000300001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验